Skip to main content

2 Result(s)

within Sigal Kaplan Remove this filter Drug Safety and Pharmacovigilance Remove this filter

and

  1. No Access

    Article

    Pregnancy, Fetal, and Infant Outcomes Following Maternal Exposure to Glatiramer Acetate During Pregnancy and Breastfeeding

    Published data support the safety of glatiramer acetate in patients with multiple sclerosis who are pregnant or breastfeeding, but long-term data are limited.

    Sigal Kaplan, Mikhail Zeygarnik, Tal Stern in Drug Safety (2022)

  2. No Access

    Article

    Effectiveness of Risk Minimization Measures for Fentanyl Buccal Tablet (FENTORA) in Canada: A Mixed-Methods Evaluation Using Surveys, Medical Chart Records and Web Surveillance

    Fentanyl buccal tablet (FBT), a potent opioid, was approved in Canada in 2013 for breakthrough pain in opioid-tolerant adult cancer patients. Additional risk minimization measures (aRMMs), consisting of commun...

    Sigal Kaplan, Aurore Bergamasco, Martin Sergerie, Anne-Marie Castilloux… in Drug Safety (2020)